Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo
The endogenous protein antizyme inhibitor (AZI) is a potential oncogene which promotes cell growth by both inhibiting antizyme (AZ) activity and releasing ornithine decarboxylase (ODC) from AZ-mediated degradation. High levels of ODC and polyamines are associated with numerous types of neoplastic tr...
Saved in:
Main Authors: | Olsen, R.R., Chung, I., Zetter, B.R. |
---|---|
Format: | Article |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/5081/1/Olsen-2012-Knockdown_of_antizym.pdf http://eprints.um.edu.my/5081/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
by: Ismail, Ruzila, et al.
Published: (2016) -
Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo
by: Chung, I., et al.
Published: (2009) -
Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma Pc-3 cells is accompanied by inactivation of nuclear factor-kappa b signaling
by: Lee, S.T., et al.
Published: (2013) -
A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis.
by: Spivey, K.A., et al.
Published: (2012) -
The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role.
by: Abdulamir, A.S., et al.
Published: (2011)